Skip main navigation
Close Drawer MenuOpen Drawer Menu

We use cookies to give you the best experience on our website. To find out more about how we use cookies and how to change your settings, see our Privacy Policy.

Accept
Hip

Is a split-dose intravenous dexamethasone regimen superior to a single high dose in reducing pain and improving function after total hip arthroplasty? A randomized blinded placebo-controlled trial

CrossMark LogoCrossMark
    Published Online:31 Oct 2020https://doi.org/10.1302/0301-620X.102B11.BJJ-2020-1078.R1

    Abstract

    Aims

    Intravenous dexamethasone has been shown to reduce immediate postoperative pain after total hip arthroplasty (THA), though the effects are short-lived. We aimed to assess whether two equivalent perioperative split doses were more effective than a single preoperative dose.

    Methods

    A total of 165 patients were randomly assigned into three groups: two perioperative saline injections (Group A, placebo), a single preoperative dose of 20 mg dexamethasone and a postoperative saline injection (Group B), and two perioperative doses of 10 mg dexamethasone (Group C). Patients, surgeons, and staff collecting outcome data were blinded to allocation. The primary outcome was postoperative pain level reported on a ten-point Numerical Rating Scale (NRS) at rest and during activity. The use of analgesic and antiemetic rescue, incidence of postoperative nausea and vomiting (PONV), CRP and interleukin-6 (IL-6) levels, range of motion (ROM), length of stay (LOS), patient satisfaction, and the incidence of surgical site infection (SSI) and gastrointestinal bleeding (GIB) in the three months postoperatively, were also compared.

    Results

    The pain scores at rest were significantly lower in Groups B and C than in Group A on postoperative days 1 and 2. The dynamic pain scores and CRP and IL-6 levels were significantly lower for Groups B and C compared to Group A on postoperative days 1, 2, and 3. Patients in Groups B and C had a lower incidence of PONV, reduced use of analgesic and antiemetic rescue, improved ROM, shorter LOS, and reported higher satisfaction than in Group A. Patients in Group C had significantly lower dynamic pain scores and IL-6 and CRP levels on postoperative days 2 and 3, and higher ROM and satisfaction on postoperative day 3 than in Group B. No SSI or GIB occurred in any group.

    Conclusion

    Perioperative dexamethasone provides short-term advantages in reducing pain, PONV, and inflammation, and increasing range of motion in the early postoperative period after THA. A split-dose regimen was superior to a single high dose in reducing pain and inflammation, and increasing ROM, with better patient satisfaction.

    Level of evidence: I

    Cite this article: Bone Joint J 2020;102-B(11):1497–1504.

    References

    • 1. Ferguson RJ, Palmer AJ, Taylor A, Porter ML, Malchau H, Glyn-Jones S. Hip replacement. Lancet. 2018;392(10158):1662–1671. Crossref, Medline, Google Scholar
    • 2. Højer Karlsen AP, Geisler A, Petersen PL, Mathiesen O, Dahl JB. Postoperative pain treatment after total hip arthroplasty: a systematic review. Pain. 2015;156(1):8–30. Crossref, Medline, ISI, Google Scholar
    • 3. Koh IJ, Chang CB, Jeon YT, Ryu JH, Kim TK. Does ramosetron reduce postoperative emesis and pain after TKA? Clin Orthop Relat Res. 2012;470(6):1718–1727. Crossref, Medline, ISI, Google Scholar
    • 4. Bedard NA, Pugely AJ, Dowdle SB, Duchman KR, Glass NA, Callaghan JJ. Opioid use following total hip arthroplasty: trends and risk factors for prolonged use. J Arthroplasty. 2017;32(12):3675–3679. Crossref, Medline, ISI, Google Scholar
    • 5. Wheeler M, Oderda GM, Ashburn MA, Lipman AG. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain. 2002;3:159–180. Crossref, Medline, ISI, Google Scholar
    • 6. Richebé P, Capdevila X, Rivat C. Persistent postsurgical pain: pathophysiology and preventative pharmacologic considerations. Anesthesiology. 2018;129(3):590–607. Crossref, Medline, ISI, Google Scholar
    • 7. Si H-B, Yang T-M, Zeng Y, et al. Correlations between inflammatory cytokines, muscle damage markers and acute postoperative pain following primary total knee arthroplasty. BMC Musculoskelet Disord. 2017;18(1):265. Crossref, Medline, Google Scholar
    • 8. Lei Y, Huang Z, Huang Q, Huang W, Pei W. Repeat doses of dexamethasone up to 48 hours further reduce pain and inflammation after total hip arthroplasty: a randomized controlled trial. J Arthroplasty. 2020. Crossref, Google Scholar
    • 9. Lei YT, Xu B, Xie XW, Xie JW, Huang Q, Pei FX. The efficacy and safety of two low-dose peri-operative dexamethasone on pain and recovery following total hip arthroplasty: a randomized controlled trial. Int Orthop. 2018;42(3):499–505. Crossref, Medline, ISI, Google Scholar
    • 10. Lei Y, Huang Q, Xu B, Zhang S, Cao G, Pei F. Multiple low-dose dexamethasone further improves clinical outcomes following total hip arthroplasty. J Arthroplasty. 2018;33(5):1426–1431. Crossref, Medline, ISI, Google Scholar
    • 11. Kardash KJ, Sarrazin F, Tessler MJ, Velly AM. Single-dose dexamethasone reduces dynamic pain after total hip arthroplasty. Anesth Analg. 2008;106(4):1253–1257. table of contents. Crossref, Medline, ISI, Google Scholar
    • 12. Dissanayake R, Du HN, Robertson IK, Ogden K, Wiltshire K, Mulford JS. Does dexamethasone reduce hospital readiness for discharge, pain, nausea, and early patient satisfaction in hip and knee arthroplasty? A randomized, controlled trial. J Arthroplasty. 2018;33(11):3429–3436. Crossref, Medline, ISI, Google Scholar
    • 13. Backes JR, Bentley JC, Politi JR, Chambers BT. Dexamethasone reduces length of hospitalization and improves postoperative pain and nausea after total joint arthroplasty: a prospective, randomized controlled trial. J Arthroplasty. 2013;28(8 Suppl):11–17. Crossref, Medline, ISI, Google Scholar
    • 14. Lunn TH, Kehlet H. Perioperative glucocorticoids in hip and knee surgery - benefit vs. harm? A review of randomized clinical trials. Acta Anaesthesiol Scand. 2013;57(7):823–834. Crossref, Medline, ISI, Google Scholar
    • 15. Lunn TH, Andersen LO, Kristensen BB, et al. Effect of high-dose preoperative methylprednisolone on recovery after total hip arthroplasty: a randomized, double-blind, placebo-controlled trial. Br J Anaesth. 2013;110(1):66–73. Crossref, Medline, ISI, Google Scholar
    • 16. Rytter S, Stilling M, Munk S, Hansen TB. Methylprednisolone reduces pain and decreases knee swelling in the first 24 h after fast-track unicompartmental knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2017;25(1):284–290. Crossref, Medline, ISI, Google Scholar
    • 17. De Luca ML, Ciccarello M, Martorana M, et al. Pain monitoring and management in a rehabilitation setting after total joint replacement. Medicine (Baltimore). 2018;97(40):e12484. Crossref, Medline, ISI, Google Scholar
    • 18. Greimel F, Dittrich G, Schwarz T, et al. Course of pain after total hip arthroplasty within a standardized pain management concept: a prospective study examining influence, correlation, and outcome of postoperative pain on 103 consecutive patients. Arch Orthop Trauma Surg. 2018;138(12):1639–1645. Crossref, Medline, ISI, Google Scholar
    • 19. Wasko MK, Bobecka-Wesolowska K, Tomasiuk R, Kowalczewski J. Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty. Clin Chem Lab Med. 2015;53(11):1785–1792. Crossref, Medline, ISI, Google Scholar
    • 20. De Oliveira GS, Almeida MD, Benzon HT, McCarthy RJ. Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology. 2011;115(3):575–588. Crossref, Medline, ISI, Google Scholar
    • 21. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494–502. Crossref, Medline, ISI, Google Scholar
    • 22. Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51(4):737–755. Crossref, Medline, ISI, Google Scholar
    • 23. Xie J, Hu Q, Ma J, Huang Q, Pei F. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhanced-recovery primary total hip arthroplasty: a randomised clinical trial. Bone Joint J. 2017;99-B(11):1442–1449. Link, ISI, Google Scholar
    • 24. Joice M, Vasileiadis GI, Amanatullah DF. Non-Steroidal anti-inflammatory drugs for heterotopic ossification prophylaxis after total hip arthroplasty: a systematic review and meta-analysis. Bone Joint J. 2018;100-B(7):915–922. Link, ISI, Google Scholar
    • 25. Maia MV, de Moraes VY, Dos Santos JB, Faloppa F, Belloti JC. Minimal important difference after hand surgery: a prospective assessment for DASH, MHQ, and SF-12. Sicot J. 2016;2:32. Crossref, Medline, ISI, Google Scholar
    • 26. Gupta A, Abubaker H, Demas E, Ahrendtsen L. A randomized trial comparing the safety and efficacy of intravenous ibuprofen versus ibuprofen and acetaminophen in knee or hip arthroplasty. Pain Physician. 2016;19(6):349–356. Medline, ISI, Google Scholar
    • 27. Tammachote N, Kanitnate S. Intravenous dexamethasone injection reduces pain from 12 to 21 hours after total knee arthroplasty: a double-blind, randomized, placebo-controlled trial. J Arthroplasty. 2020;35(2):394–400. Crossref, Medline, ISI, Google Scholar
    • 28. Dissanayake R, Du HN, Robertson IK, Ogden K, Wiltshire K, Mulford JS. Does dexamethasone reduce hospital readiness for discharge, pain, nausea, and early patient satisfaction in hip and knee arthroplasty? A randomized, controlled trial. J Arthroplasty. 2018;33(11):3429–3436. Crossref, Medline, ISI, Google Scholar
    • 29. Lei Y-T, Xu B, Xie X-W, Xie J-W, Huang Q, Pei F-X. The efficacy and safety of two low-dose peri-operative dexamethasone on pain and recovery following total hip arthroplasty: a randomized controlled trial. Int Orthop. 2018;42(3):499–505. Crossref, Medline, ISI, Google Scholar
    • 30. Pinto PR, McIntyre T, Araújo-Soares V, Costa P, Ferrero R, Almeida A. A comparison of predictors and intensity of acute postsurgical pain in patients undergoing total hip and knee arthroplasty. J Pain Res. 2017;10:1087–1098. Crossref, Medline, ISI, Google Scholar
    • 31. Busse P, Vater C, Stiehler M, et al. Cytotoxicity of drugs injected into joints in orthopaedics. Bone Joint Res. 2019;8(2):41–48. Link, ISI, Google Scholar
    • 32. Hall GM, Peerbhoy D, Shenkin A, Parker CJ, Salmon P. Relationship of the functional recovery after hip arthroplasty to the neuroendocrine and inflammatory responses. Br J Anaesth. 2001;87(4):537–542. Crossref, Medline, ISI, Google Scholar
    • 33. Ibrahim MS, Khan MA, Nizam I, Haddad FS. Peri-operative interventions producing better functional outcomes and enhanced recovery following total hip and knee arthroplasty: an evidence-based review. BMC Med. 2013;11:37. Crossref, Medline, ISI, Google Scholar
    • 34. Tang X, Teng S, Petri M, Krettek C, Liu C, Jagodzinski M. The effect of anti-inflammatory and antifibrotic agents on fibroblasts obtained from arthrofibrotic tissue: An in vitro and in vivo study. Bone Joint Res. 2018;7(3):213–222. Link, ISI, Google Scholar
    • 35. Cao X, White PF, Ma H. An update on the management of postoperative nausea and vomiting. J Anesth. 2017;31(4):617–626. Crossref, Medline, ISI, Google Scholar
    • 36. Li X, Sun Z, Han C, He L, Wang B. A systematic review and meta-analysis of intravenous glucocorticoids for acute pain following total hip arthroplasty. Medicine (Baltimore). 2017;96(19):e6872. Crossref, Medline, ISI, Google Scholar
    • 37. Richardson AB, Bala A, Wellman SS, Attarian DE, Bolognesi MP, Grant SA. Perioperative dexamethasone administration does not increase the incidence of postoperative infection in total hip and knee arthroplasty: a retrospective analysis. J Arthroplasty. 2016;31(8):1784–1787. Crossref, Medline, ISI, Google Scholar
    • 38. Godshaw BM, Mehl AE, Shaffer JG, et al. The effects of peri-operative dexamethasone on patients undergoing total hip or knee arthroplasty: is it safe for diabetics? J Arthroplasty. 2019;34(4):645–649. Crossref, Medline, ISI, Google Scholar
    • 39. Onggo JR, Onggo JD, de Steiger R, Hau R. Greater risks of complications, infections, and revisions in the obese versus non-obese total hip arthroplasty population of 2,190,824 patients: a meta-analysis and systematic review. Osteoarthritis Cartilage. 2020;28(1):31–44. Crossref, Medline, ISI, Google Scholar

    Submit a Letter to the Editor about this article